Results - Announcements
Sudeep Pharma Ltd share price rallied 9.21% to Rs 1116.05 after the company's net profit jumped 27.64% to Rs 51.81 crore, while revenue from operations gained significantly 24.28% to Rs 196.7 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.30%. It has marginally improved by 3.87% over last one week and gained upto 0.06% in last one month while the market capitalization of Sudeep Pharma Ltd has significantly gained 15.62% and 26.91% in the same period respectively.
Profit before tax (PBT) of Sudeep Pharma Ltd stood at Rs 71.03 crore in Q3 FY26, jumping 19.32% year-on-year, and expanding by 30.83% quarter-on-quarter. EBITDA came in at Rs 67 crore, surging by 48.51% YoY and rallying 35.99% sequentially.
Total expenses jumped by 20.01% to Rs 128.84 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 71.37 crore, growing marginally by 3.72% YoY, while employee benefits expense was at Rs 15.61 crore, improving by 8.86% YoY.
For the TTM ended FY26, revenue from operations surged 27.94% to Rs 642.26 crore, while net profit saw a strong growth of 25.63% to Rs 174.28 crore, compared to previous TTM. EBITDA surged by 18384% to Rs 193.31 crore, and PBT witnessed a strong rise of 24.73% to Rs 228.07 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 69.55 crore in FY26, as against Rs 48.73 crore in FY25.
Sudeep Pharma Ltd surged by 44.25% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.45% during the same period.